Therapy Area topics


Vantage logo

New US nod widens the net for Entresto

Entresto can now be used in five million of six million US heart failure patients, but Novartis admits ramp-up in the new population will be slow.

Central Nervous System

Digital Health

Vantage logo

Onduo takes its time

The Verily subsidiary has the luxury of patient backers. But hungrier rivals could steal a march.




Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.